![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eirx Therap. | LSE:ERX | London | Ordinary Share | GB00B0XQBS97 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.015 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:5114O EiRx Therapeutics PLC 21 February 2008 TR-1: Notifications of Major Interests in Shares 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Eirx Therapeutics Plc 2. Reason for notification (yes/no) An acquisition or disposal of voting rights YES An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached NO An event changing the breakdown of voting rights NO Other (please specify):______________ NO 3. Full name of person(s) subject to notification obligation: Barclays PLC 4. Full name of shareholder(s) (if different from 3): Barclays Stockbrokers Ltd 5. Date of transaction (and date on which the threshold is crossed or reached if different): 19 February 2008 6. Date on which issuer notified: 20 February 2008 7. Threshold(s) that is/are crossed or reached: 6% to 7% 8. Notified details: N/A A: Voting rights attached to shares Class/type of Situation previous to the Resulting situation after the triggering transaction shares triggering transaction Number of Number of Number of Number of voting rights Percentage of voting If possible use shares voting shares rights ISIN code rights Direct Direct Indirect Direct Indirect GB00B0XQBS97 187,968,924 187,968,924 211,630,528 0 211,630,528 0.00 7.11 B: Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of voting instrument period/date that may be acquired rights (if the instrument exercised/converted) N/A N/A N/A N/A N/A Total (A+B) Number of voting rights Percentage of voting rights 211,630,528 7.11 9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: Barclays Stockbrokers Ltd Proxy Voting: 10. Name of proxy holder: N/A 11. Number of voting rights proxy holder will cease N/A to hold: 12. Date on which proxy holder will cease to hold N/A voting rights: 13. Additional information: N/A 14 Contact name: Geoff Smith 15. Contact telephone name: 0207 116 2913 For notes on how to complete form TR-1 please see the FSA website. This information is provided by RNS The company news service from the London Stock Exchange END HOLUAUNRWSRUUAR
1 Year Eirx Therapeutics Chart |
1 Month Eirx Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions